Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 6,020.00
-120.00 (-1.95%)
At close: Oct 2, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 77.93 billion as of October 2, 2026. Its market cap has increased by 6.74% in one year.
Market Cap
77.93B
Enterprise Value
64.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6,020.00
ChartMarket Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 77.93B, a decrease of -30.90%. That is a compound annual growth rate of -10.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 77.93B | -35.89% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| KOREA PHARMA | 95.11B |
| DongKoo Bio & Pharma | 95.05B |
| H.PIO | 87.34B |
| Samik Pharmaceutical Company LTD. | 86.08B |
| Sam-A Pharm. | 84.53B |
| Daehan Nupharm | 78.46B |
| Sinil Pharmaceutical | 73.72B |
| Polaris AI Pharma | 72.66B |